透明超声凝胶垫作为放疗补偿物在表面引导放疗中的应用
本研究评估了将透明超声凝胶垫重新用作放疗补偿物的可行性,重点分析其剂量学表现和与表面引导放疗(SGRT)的兼容性。该凝胶垫由罗望子籽胶和多元醇组成,与常规凝胶补偿物和热塑性补偿物进行对比。结果显示透明凝胶垫在保持补偿物功能的同时,可直接实现SGRT对下方皮肤表面的识别。
要点
- 透明凝胶垫在730 nm处透光率达92.3%,远高于常规补偿物。
- SGRT识别率为89.10%,与无补偿物条件(92.93%)相近。
- 6 MV光子线浅表剂量增强低于常规材料(85.5% vs 90.3–91.5%)。
核心结论
- 透明凝胶垫补偿物在维持临床相关补偿物功能的同时,实现了SGRT对下方皮肤表面的直接识别。
- 光学透明性使SGRT能够穿透补偿物进行监测,提示光学兼容性是补偿物设计的重要考量因素。
研究设计与样本
- 研究类型为可行性研究,评估透明超声凝胶垫重新用作放疗补偿物的剂量学性能和SGRT兼容性。
- 凝胶垫补偿物成分为罗望子籽胶和多元醇,对照组为常规凝胶补偿物和热塑性补偿物。
- 测量6 MV和10 MV光子束及6 MeV和9 MeV电子束的百分深度剂量。
- 使用AlignRT SGRT系统在乳腺体模上量化表面识别准确率。
关键影像表现/征象
- 凝胶垫对光子和电子束均产生了可测量的补偿物效应。
- 光子束在dmax以深的剂量与常规材料相差在1%以内。
- 730 nm处凝胶垫补偿物透光率为92.3%,凝胶补偿物为19.8%,热塑性补偿物为36.6%。
诊断标准与关键数值
- 6 MV时凝胶垫浅表剂量增强为85.5%,常规材料为90.3%–91.5%。
- SGRT识别率:凝胶垫补偿物为89.10%,无补偿物条件为92.93%(p = 0.13)。
- 常规补偿物的SGRT识别率显著降低(p < 0.001)。
- 光学透射率在380–830 nm范围内评估,730 nm处透光率最高。
临床应用与阅片要点
- 透明凝胶垫可用于需要SGRT监测且同时需要组织等效补偿的放疗场景。
- 选用补偿物时需关注光学透射率,以保证SGRT系统对皮肤表面的持续识别能力。
- 光子束浅表剂量增强较常规材料偏低,需在计划系统中针对实际补偿物参数进行剂量验证。
局限性
- 研究基于乳腺体模,未在真实患者上进行SGRT识别率验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the feasibility of repurposing a transparent ultrasound gel pad as a radiotherapy bolus, we focused on dosimetric performance and compatibility with surface-guided radiation therapy (SGRT).
METHODS: A gel pad bolus composed of tamarind seed gum and polyhydric alcohols was compared with a conventional gel bolus and a thermoplastic bolus. Percent depth dose was measured for 6 MV and 10 MV photon beams and 6 MeV and 9 MeV electron beams. Straight-line optical transmittance was assessed over 380-830 nm. Surface recognition accuracy was quantified using the AlignRT SGRT system on a breast phantom.
RESULTS: The gel pad produced a measurable bolus effect for both photon and electron beams, although superficial dose enhancement was lower than that of conventional materials (85.5% vs 90.3-91.5% at 6 MV). Deep doses beyond dmax agreed within 1% for photon beams. At 730 nm, the gel pad bolus demonstrated high transmittance (92.3%), compared with the gel (19.8%) and HM (36.6%) boluses. The SGRT recognition rate with the gel pad bolus (89.10%) was comparable to the no-bolus condition (92.93%, p = 0.13), whereas conventional boluses significantly reduced recognition (p < 0.001).
CONCLUSIONS: The transparent gel pad bolus enabled direct SGRT-based recognition of the underlying skin surface while maintaining clinically relevant bolus functionality.
ADVANCES IN KNOWLEDGE: Optical transparency enables SGRT monitoring through a bolus, highlighting optical compatibility as an important design consideration.
引用
- Hirano, Matsumoto, Otsuka, et al. A transparent gel pad bolus enabling direct skin recognition in surface-guided radiation therapy. Br J Radiol. 2026. PMID: 42904825. doi:10.1093/bjr/tqag256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。